LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Gwynn, Simon"
  2. AU="Holper, Sarah"
  3. AU="Haider, Farag Ibrahim"
  4. AU="Rice, Jordin L"
  5. AU="Gong, Xingguo"
  6. AU=Rother Magdalena B.
  7. AU="Petrov, Ksenia"
  8. AU="Rijneveld, R"
  9. AU=Lopez-Martinez Briceida
  10. AU=Astone Pia
  11. AU="Amaral, V"

Search results

Result 1 - 4 of total 4

Search options

  1. Article: Establishing Expert, Multi-Disciplinary, Peer-Reviewed Consensus to Lead a Paradigm Shift in Optimal Blood Glucose Management.

    Robertson, Douglas A / Chudleigh, Richard A / Gwynn, Simon D / Jairam, Carol / Kansagra, Kaushal / Kanumilli, Naresh / Lester-George, Adam / McMurray, Charlotte / Warren, Timothy C

    Diabetes therapy : research, treatment and education of diabetes and related disorders

    2019  Volume 10, Issue 3, Page(s) 901–916

    Abstract: Introduction: The National Health Service (NHS) in the UK appears unclear on how blood glucose monitoring (BGM) should be used to support diabetes patient care and empowerment, and local interpretation of NICE guidance on the availability of devices ... ...

    Abstract Introduction: The National Health Service (NHS) in the UK appears unclear on how blood glucose monitoring (BGM) should be used to support diabetes patient care and empowerment, and local interpretation of NICE guidance on the availability of devices varies widely. An expert group of clinicians and commissioners considered BGM in terms of access, guidance, resources, data integration, patient education, and patient choice.
    Methods: The group generated a series of questions on BGM into a 38-statement questionnaire using Delphi methodology. This was circulated to clinicians involved in diabetes management across the UK, receiving 222 responses.
    Results: From the questionnaire, 35 of the 38 statement responses showed > 66% consensus, with 26 of these achieving > 90% agreement.
    Conclusion: The expert group reviewed the responses and made recommendations based on the clear professional consensus demonstrated. These included the need to use new technology and data integration and that wider factors, including patient choice rather than cost alone, should inform formulary inclusion of BGM equipment.
    Funding: LifeScan U.K. Ltd.
    Language English
    Publishing date 2019-03-19
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2566702-6
    ISSN 1869-6961 ; 1869-6953
    ISSN (online) 1869-6961
    ISSN 1869-6953
    DOI 10.1007/s13300-019-0598-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Inflammatory bowel disease and Clostridium difficile infection: contrasting views of international clinical professionals.

    Stallmach, Andreas / Anttila, Veli-Jukka / Hell, Markus / Gwynn, Simon / Merino-Amador, Paloma / Petrosillo, Nicola / Ráčil, Zdenek / Warren, Tim / Wenisch, Christoph / Wilcox, Mark

    Zeitschrift fur Gastroenterologie

    2018  

    Abstract: Introduction: In patients with inflammatory bowel disease (IBD), Clostridium difficile infection (CDI) is a risk factor for both morbidity and mortality. Currently, appropriate management is unclear. Guidance on best practice in the diagnosis and ... ...

    Title translation Chronisch-entzündliche Darmerkrankung und Clostridium difficile Infektionen: unterschiedliche Ansichten in unterschiedlichen Schwerpunkten.
    Abstract Introduction: In patients with inflammatory bowel disease (IBD), Clostridium difficile infection (CDI) is a risk factor for both morbidity and mortality. Currently, appropriate management is unclear. Guidance on best practice in the diagnosis and treatment of CDI in IBD patients is therefore needed.
    Methods: A multidisciplinary group of clinicians involved in the treatment of patients with IBD and CDI developed 27 consensus statements. Respondents were asked to rate their agreement with each statement using a 4-point Likert scale. A modified Delphi methodology was used to review responses of 442 physicians from different specialties (including infectious disease specialists [n = 104], microbiologists [n = 95], and gastroenterologists [n = 73]). A threshold of 75 % agreement was predefined as consensus.
    Results: Consensus was achieved for 17 of the 27 statements. Unprompted recognition of risk factors for CDI was low. Intensification of immunosuppressive therapy in the absence of clinical improvement was controversial. Clear definitions of treatment failure of antibiotic therapy in CDI and recurrence of CDI in IBD are needed. Respondents require further clarity regarding the place of fecal microbiota transplantation in CDI patients with IBD. Differences were observed between the perceptions of microbiologists and gastroenterologists, as well as between countries.
    Conclusions: Different perceptions both between specialties and geographical locations complicate the development of an internationally accepted algorithm for the diagnosis and treatment of CDI in patients with IBD. This study highlights the need for future studies in this area.
    Language English
    Publishing date 2018-02-09
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 201387-3
    ISSN 1439-7803 ; 0172-8504 ; 0044-2771
    ISSN (online) 1439-7803
    ISSN 0172-8504 ; 0044-2771
    DOI 10.1055/s-0044-100045
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Highlighting the clinical need for diagnosing Mycoplasma genitalium infection.

    Ison, Catherine A / Fifer, Helen / Gwynn, Simon / Horner, Paddy / Muir, Peter / Nicholls, Jane / Radcliffe, Keith / Ross, Jonathan / Taylor-Robinson, David / White, John

    International journal of STD & AIDS

    2018  Volume 29, Issue 7, Page(s) 680–686

    Abstract: Despite Mycoplasma genitalium (MG) being increasingly recognised as a genital pathogen in men and women, awareness and utility of commercially available MG-testing has been low. The opinion of UK sexual health clinicians and allied professionals was ... ...

    Abstract Despite Mycoplasma genitalium (MG) being increasingly recognised as a genital pathogen in men and women, awareness and utility of commercially available MG-testing has been low. The opinion of UK sexual health clinicians and allied professionals was sought on how MG-testing should be used. Thirty-two consensus statements were developed by an expert group and circulated to clinicians and laboratory staff, who were asked to evaluate their level of agreement with each statement; 75% agreement was set as the threshold for defining consensus for each statement. A modified Delphi approach was used and high levels of agreement obviated the need to test the original statement set further. Of 201 individuals who received questionnaires, 60 responded, most (48) being sexual health consultants, more than 10% of the total in the UK. Twenty-seven (84.4%) of the statements exceeded the 75% threshold. Respondents strongly supported MG-testing of patients with urethritis, pelvic inflammatory disease or unexplained persistent vaginal discharge, or post-coital bleeding. Fewer favoured testing patients with proctitis and support was divided for routinely testing Chlamydia-positive patients. Testing of current sexual contacts of MG-positive patients was supported, as was a test of cure for MG-positive patients, although agreement fell below the 75% threshold. Respondents agreed that all consultant- or specialist-led services should have access to testing for MG (98.3%). There was strong agreement for having MG-testing available for specific patient groups, which may reflect concern over antibiotic resistance and the desire to comply with clinical guidelines that recommend MG-testing in sexual health clinic settings.
    MeSH term(s) Adult ; Anti-Bacterial Agents/therapeutic use ; Evidence-Based Practice ; Expert Testimony ; Female ; Humans ; Male ; Middle Aged ; Mycoplasma Infections/diagnosis ; Mycoplasma Infections/drug therapy ; Mycoplasma Infections/microbiology ; Mycoplasma genitalium/isolation & purification ; Mycoplasma genitalium/pathogenicity ; Practice Guidelines as Topic ; United Kingdom
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2018-02-10
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1018089-8
    ISSN 1758-1052 ; 0956-4624
    ISSN (online) 1758-1052
    ISSN 0956-4624
    DOI 10.1177/0956462417753527
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Inflammatory bowel disease and Clostridium difficile infection: contrasting views of international clinical professionals

    Stallmach, Andreas / Anttila, Veli-Jukka / Hell, Markus / Gwynn, Simon / Merino-Amador, Paloma / Petrosillo, Nicola / Ráčil, Zdenek / Warren, Tim / Wenisch, Christoph / Wilcox, Mark

    Zeitschrift für Gastroenterologie

    2018  Volume 56, Issue 07, Page(s) 731–737

    Abstract: Introduction: In patients with inflammatory bowel disease (IBD), Clostridium difficile infection (CDI) is a risk factor for both morbidity and mortality. Currently, appropriate management is unclear. Guidance on best practice in the diagnosis and ... ...

    Abstract Introduction: In patients with inflammatory bowel disease (IBD), Clostridium difficile infection (CDI) is a risk factor for both morbidity and mortality. Currently, appropriate management is unclear. Guidance on best practice in the diagnosis and treatment of CDI in IBD patients is therefore needed.
    Methods: A multidisciplinary group of clinicians involved in the treatment of patients with IBD and CDI developed 27 consensus statements. Respondents were asked to rate their agreement with each statement using a 4-point Likert scale. A modified Delphi methodology was used to review responses of 442 physicians from different specialties (including infectious disease specialists [n = 104], microbiologists [n = 95], and gastroenterologists [n = 73]). A threshold of 75 % agreement was predefined as consensus.
    Results: Consensus was achieved for 17 of the 27 statements. Unprompted recognition of risk factors for CDI was low. Intensification of immunosuppressive therapy in the absence of clinical improvement was controversial. Clear definitions of treatment failure of antibiotic therapy in CDI and recurrence of CDI in IBD are needed. Respondents require further clarity regarding the place of fecal microbiota transplantation in CDI patients with IBD. Differences were observed between the perceptions of microbiologists and gastroenterologists, as well as between countries.
    Conclusions: Different perceptions both between specialties and geographical locations complicate the development of an internationally accepted algorithm for the diagnosis and treatment of CDI in patients with IBD. This study highlights the need for future studies in this area.
    Keywords Chronisch-entzündliche Darmerkrankung ; Clostridium difficile Infektionen ; Konsensbericht ; inflammatory bowel disease ; clostridium difficile infection ; consensus report
    Language English
    Publishing date 2018-02-09
    Publisher © Georg Thieme Verlag KG
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 201387-3
    ISSN 1439-7803 ; 0044-2771 ; 0172-8504
    ISSN (online) 1439-7803
    ISSN 0044-2771 ; 0172-8504
    DOI 10.1055/s-0044-100045
    Database Thieme publisher's database

    More links

    Kategorien

To top